Chromium-based ethylene tetramerization catalyst precursors of the type {(DPPME)CrCl 2 (μ-Cl)} 2 with a chiraphos ligand backbone [DPPME = {Ar(R 1 R 2 )} 2 PCH(CH 3 )CH(CH 3 )P{Ar(R 1 R 2 )} 2 ] were prepared and characterized, in which substituents on the aryl phosphine varied with electron-donating and -withdrawing groups ( S, S -ArR 1 = H, R 2 = H 1; R, R -ArR 1 = H, R 2 = H 2; meso -ArR 1 = H, R 2 = H 3; S, S -ArR 1 = Me, R 2 = H 4; S, S -ArR 1 = OMe, R 2 = H 5; S, S -ArR 1 = H, R 2 = Me 6; S, S -ArR 1 = H, R 2 = OMe 7; S, S -ArR 1 = H, R 2 = F 8 ). Depending on the coordination of chiraphos or achiraphos ligands, the corresponding bimetallic chromium complexes were prepared from the reaction of CrCl 3 (THF) 3 . S,S - and R,R -Chiraphos-based chromium metal complexes, 9 and 10, were crystallographically characterized to be dimeric, bridged by two chlorine ligands, whereas a meso achiraphos ligand resulted in a monomeric chromium complex, 17, when crystallized in acetonitrile. The observed average Cr−P bond distances of 9 [2.491(1) Å] and 10 [2.489(2) Å] were shorter than those found in 17 [2.512(1) Å]. The bite angles of 9 and 10 [79.45(6)° and 79.91(8)°] were also smaller than those of 17 [82.06(5)°]. Isolated chiraphos-based Cr(III) precursors, 9 − 16, exhibited enhanced ethylene tetramerization activities in the range 274−2,256 kg/g Cr/h when 30 bar of ethylene was engaged in the presence of MMAO-12A. Further, methyl substitution at the para -position of the phenyl group on the S,S -chiraphos ligand produced the expected chromium dimer, [CrCl 2 (μ-Cl){( P,P )-κ 2 -( S, S -DPPDME- 6 )}] 2 ( 14 ), and exhibited higher catalytic performance, reaching a 1-octene activity of 2256 kg/g Cr/h with 51.1% selectivity at 45 °C. Further, temperature control at 25 °C increased 1-octene selectivity to 77.4% at the expense of reduced activity of 580 kg/g Cr/h. DFT calculations on the seven-membered metallacycle intermediates suggested stronger Cr−P bonding with a S,S -/ R,R -chiraphos ligand backbone, and this interaction can be related to the enhanced catalytic performance.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: